Vaarala M - Search Results

1

Estrogen receptor-α and sex steroid hormones regulate Toll-like receptor-9 expression and invasive function in human breast cancer cells.

Sandholm J, Kauppila JH, Pressey C, Tuomela J, Jukkola-Vuorinen A, Vaarala M, Johnson MR, Harris KW, Selander KS. Sandholm J, et al. Among authors: vaarala m. Breast Cancer Res Treat. 2012 Apr;132(2):411-9. doi: 10.1007/s10549-011-1590-3. Epub 2011 May 24. Breast Cancer Res Treat. 2012. PMID: 21607583

2

Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.

Väisänen MR, Väisänen T, Jukkola-Vuorinen A, Vuopala KS, Desmond R, Selander KS, Vaarala MH. Väisänen MR, et al. Prostate. 2010 Jun 1;70(8):817-24. doi: 10.1002/pros.21115. Prostate. 2010. PMID: 20054821

3

Tumor infiltrating CD8⁺ T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma.

Mella M, Kauppila JH, Karihtala P, Lehenkari P, Jukkola-Vuorinen A, Soini Y, Auvinen P, Vaarala MH, Ronkainen H, Kauppila S, Haapasaari KM, Vuopala KS, Selander KS. Mella M, et al. Among authors: vaarala mh. Oncoimmunology. 2015 May 22;4(6):e1002726. doi: 10.1080/2162402X.2014.1002726. eCollection 2015 Jun. Oncoimmunology. 2015. PMID: 26155410 Free PMC article.

4

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma.

Ronkainen H, Hirvikoski P, Kauppila S, Vuopala KS, Paavonen TK, Selander KS, Vaarala MH. Ronkainen H, et al. J Exp Clin Cancer Res. 2011 Sep 19;30(1):84. doi: 10.1186/1756-9966-30-84. J Exp Clin Cancer Res. 2011. PMID: 21929816 Free PMC article.

5

Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer.

Väisänen MR, Jukkola-Vuorinen A, Vuopala KS, Selander KS, Vaarala MH. Väisänen MR, et al. Oncol Lett. 2013 May;5(5):1659-1663. doi: 10.3892/ol.2013.1204. Epub 2013 Feb 20. Oncol Lett. 2013. PMID: 23761830 Free PMC article.

6

CIP2A expression is increased in prostate cancer.

Vaarala MH, Väisänen MR, Ristimäki A. Vaarala MH, et al. J Exp Clin Cancer Res. 2010 Oct 21;29(1):136. doi: 10.1186/1756-9966-29-136. J Exp Clin Cancer Res. 2010. PMID: 20964854 Free PMC article.

7

Myosin VI is a modulator of androgen-dependent gene expression.

Loikkanen I, Toljamo K, Hirvikoski P, Väisänen T, Paavonen TK, Vaarala MH. Loikkanen I, et al. Oncol Rep. 2009 Nov;22(5):991-5. doi: 10.3892/or_00000526. Oncol Rep. 2009. PMID: 19787211

8

Sorbitol dehydrogenase expression is regulated by androgens in the human prostate.

Szabó Z, Hämäläinen J, Loikkanen I, Moilanen AM, Hirvikoski P, Väisänen T, Paavonen TK, Vaarala MH. Szabó Z, et al. Oncol Rep. 2010 May;23(5):1233-9. doi: 10.3892/or_00000755. Oncol Rep. 2010. PMID: 20372835

9

A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding.

Huang Q, Whitington T, Gao P, Lindberg JF, Yang Y, Sun J, Väisänen MR, Szulkin R, Annala M, Yan J, Egevad LA, Zhang K, Lin R, Jolma A, Nykter M, Manninen A, Wiklund F, Vaarala MH, Visakorpi T, Xu J, Taipale J, Wei GH. Huang Q, et al. Among authors: vaarala mh. Nat Genet. 2014 Feb;46(2):126-35. doi: 10.1038/ng.2862. Epub 2014 Jan 5. Nat Genet. 2014. PMID: 24390282

10

Evaluation of neuroendocrine markers in renal cell carcinoma.

Ronkainen H, Soini Y, Vaarala MH, Kauppila S, Hirvikoski P. Ronkainen H, et al. Diagn Pathol. 2010 May 12;5:28. doi: 10.1186/1746-1596-5-28. Diagn Pathol. 2010. PMID: 20462442 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters